Assembly Biosciences (ASMB) Short-term Investments (2015 - 2026)

Assembly Biosciences' Short-term Investments history runs 12 years deep, the most recent figure standing at $195.5 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 189.11% year-over-year to $195.5 million; the TTM figure through Mar 2026 stood at $195.5 million (up 189.11% YoY), while the FY2025 annual figure was $189.7 million, up 157.21% from the prior year.
• Short-term Investments for Q1 2026 stood at $195.5 million, up from $189.7 million in the prior quarter.
• The five-year high for Short-term Investments was $210.0 million in Q3 2025, with the low at $19.6 million in Q3 2023.
• The 5-year median for Short-term Investments is $71.8 million (2022), against an average of $86.7 million.
• The sharpest annual moves came in 2023 and 2024: Short-term Investments plunged 63.77% in 2023, then jumped 240.09% in 2024.
• Assembly Biosciences' Short-term Investments stood at $39.2 million in 2022, then soared by 181.71% to $110.4 million in 2023, then tumbled by 33.21% to $73.7 million in 2024, then soared by 157.21% to $189.7 million in 2025, then grew by 3.07% to $195.5 million in 2026.
• Business Quant data shows ASMB's Short-term Investments at $195.5 million in Q1 2026, $189.7 million in Q4 2025, and $210.0 million in Q3 2025.